Immunology and Microbiology
ABO Blood Group System
14%
Age
38%
Animal
6%
Antibody Screening
28%
Azathioprine
14%
Blood Group O
14%
Blood Plasma
14%
Comorbidity
15%
COVID-19
61%
ELISA
14%
Fitness
14%
Genotype
5%
Hepatitis E
17%
Hepatitis E Virus
19%
Immunity
5%
Immunoassay
14%
Immunocompromised Patient
14%
Immunoglobulin G
16%
Immunoglobulin G Antibody
5%
Immunoglobulin M
6%
Inflammatory Bowel Disease
14%
Infliximab
14%
Intravenous Immunoglobulin
6%
Monospecific Antibody
62%
Mortality Rate
28%
Neovison Vison
14%
Neutralization
16%
Neutralizing Antibody
14%
Pharmacokinetics
14%
Pig
5%
Prevalence
40%
Sample
14%
Seropositivity
26%
Seroprevalence
38%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Time
24%
Viral Disease
18%
Virus
23%
Medicine and Dentistry
Adult
14%
Adverse Event
15%
Age
16%
Alertness
14%
Antibody
20%
Assay
19%
Blood
9%
Blood Donor
64%
Blood Group ABO System
14%
Blood Group O
14%
Cohort Effect
14%
COVID-19
8%
Donor
27%
Epidemic
16%
Evaluation Study
14%
Genotype
5%
Hepatitis E
14%
Hepatitis E Virus
19%
Immunoassay
5%
Immunocompromised Patient
14%
Immunoglobulin G
7%
Infection
80%
Mortality Rate
42%
Nucleic Acid
14%
Patient
11%
Plasma
14%
Pneumonia
14%
Polymerase Chain Reaction
8%
Prevalence
23%
Reinfection
14%
RNA
14%
Seroprevalence
25%
Severe Acute Respiratory Syndrome Coronavirus 2
57%
Transfusion
17%
Virus Infection
15%